VMVAX | VVMCX | VMVAX / VVMCX | |
Total Expense Ratio | 0.07 | 0.82 | 9% |
Annual Report Gross Expense Ratio | 0.07 | 0.82 | 9% |
Fund Existence | 14 years | 27 years | - |
Gain YTD | 5.198 | -4.025 | -129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 31B | 601M | 5,158% |
Annual Yield % from dividends | 2.22 | 0.73 | 304% |
Returns for 1 year | 7.67 | -0.33 | -2,315% |
Returns for 3 years | 17.51 | -15.05 | -116% |
Returns for 5 years | 65.15 | 14.23 | 458% |
Returns for 10 years | 87.87 | -20.92 | -420% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IQSI | 33.86 | 0.21 | +0.64% |
NYLI Candriam International Equity ETF | |||
CPSM | 28.07 | -0.01 | -0.04% |
Calamos S&P 500 Str Alt Prt ETF-May | |||
SCHX | 25.47 | -0.06 | -0.24% |
Schwab US Large-Cap ETF™ | |||
CHY | 10.84 | -0.03 | -0.28% |
Calamos Convertible and High Income Fund | |||
NULC | 50.47 | -0.26 | -0.51% |
Nuveen ESG Large-Cap ETF |